NLRP3 and metabolic dysfunction-associated steatotic liver disease: We then demonstrated that novel-miR-7 was abundant in MVECs after incubation of NAFLD hepatic sEVs, while overexpression of novel-miR-7 promoted microvascular endothelial barrier function through NLRP3 inflammasome activation.